C. Eric Winzer - Aug 1, 2025 Form 4/A - Amendment Insider Report for Nuo Therapeutics, Inc. (AURX)

Role: Director
Signature: /s/ David Jorden, attorney-in-fact
Stock symbol: AURX
Transactions as of: Aug 1, 2025
Transactions value $: -$1
Form type: 4/A - Amendment
Date filed: 8/4/2025, 09:36 AM
Date Of Original Report: Aug 4, 2025
Previous filing: Jul 22, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WINZER C ERIC	Director	C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON	/s/ David Jorden, attorney-in-fact	2025-08-04	0001205362

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AURX	Common Stock	Options Exercise	$48.1K	+120K	+481.25%	$0.40	145K	Aug 1, 2025	Direct
transaction	AURX	Common Stock	Tax liability	-$48.1K	-27.7K	-19.03%	$1.74	118K	Aug 1, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AURX	Option to purchase common stock	Options Exercise	$0	-120K	-100%	$0.00	0	Aug 9, 2018	Common Stock	120K	$0.40	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a net exercise of outstanding stock options. The reporting person received 92,654 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock. The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74.